Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.
It’s rare but men can also be diagnosed with breast cancer, the NHS website explains. The NHS encourages women to check their breasts regularly for any changes and says they should always get ...
Official figures show around 30 per cent of people invited for free NHS bowel cancer testing do not take up the invitation. A further 35 per cent of women don't attend breast screening ...
and now certain breast cancer patients can benefit from the drug on the NHS. “It’s fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted ...
Nearly 700,000 women across the country will take part in a world-leading trial to test how AI tools can be used to catch breast cancer cases earlier ...